OXIGENESIS INC – Trademark Portfolio

Entity Type: 03

OXIGENESIS INC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BABY2, BABYO2, OXYSALINE, CHERRY BO2MB, and PEACE LOVE RALLY. The owner is based in PASO ROBLES, CA.

2917 UNION ROAD, SUITE B

PASO ROBLES, CA 93446

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

OXIGENESIS INC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does OXIGENESIS INC have?

OXIGENESIS INC has 11 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 1 cancelled.

What trademark classes does OXIGENESIS INC file in?

OXIGENESIS INC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are OXIGENESIS INC's most well-known trademarks?

OXIGENESIS INC's registered trademark portfolio includes well-known marks such as BABY2, BABYO2, OXYSALINE, CHERRY BO2MB, and PEACE LOVE RALLY. These are among 6 currently registered trademarks in the portfolio.

What is OXIGENESIS INC's trademark registration success rate?

OXIGENESIS INC has a 55% trademark registration rate, with 6 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.